Microbiome Metabolomics in Diabetes

The gut microbiome plays a significant role in metabolic health, and its alteration is linked to the development of diabetes. Microbiome metabolomics, which studies the metabolites produced by gut bacteria, sheds light on how these microbial communities influence glucose metabolism and insulin sensitivity. In people with Type 2 Diabetes (T2D), changes in the gut microbiota can lead to increased production of harmful metabolites like lipopolysaccharides (LPS), which trigger systemic inflammation. On the other hand, beneficial metabolites such as short-chain fatty acids (SCFAs), which improve insulin sensitivity, are often reduced in diabetic individuals. Modifying the gut microbiome through diet, probiotics, or targeted therapies offers new opportunities to manage blood sugar levels, reduce inflammation, and improve metabolic outcomes in diabetes.